Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis
Author:
Funder
MINECO
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference77 articles.
1. Current perspectives on the immunopathogenesis of systemic sclerosis;Fuschiotti;Immunotargets Ther.,2016
2. Pathogenesis of Systemic Sclerosis;Pattanaik;Front. Immunol.,2015
3. Pathologic observations in systemic sclerosis (scleroderma) A study of fifty-eight autopsy cases and fifty-eight matched controls;D'Angelo;Am. J. Med.,1969
4. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection;Cool;Hum. Pathol.,1997
5. Autopsy case of systemic sclerosis with severe pulmonary hypertension;Nagai;J. Dermatol.,2007
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Characteristics of n6-methyladenosine (m6A) regulators and role of FTO/TNC in scleroderma;Gene;2024-02
2. An overview on synthetic and biological activities of cannabidiol (CBD) and its derivatives;Bioorganic Chemistry;2023-11
3. Cannabidiol goes nuclear: The role of PPARγ;Phytomedicine;2023-06
4. Cannabinoids And Cannabinoid-Like Compounds: Biochemical Characterization And Pharmacological Perspectives;Russian Open Medical Journal;2023-03-28
5. Identification of Novel CB2 Ligands through Virtual Screening and In Vitro Evaluation;Journal of Chemical Information and Modeling;2023-01-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3